Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piera Capranzano

Showing results (61-70 of 224) with videos related to

Pageof 23
Sort By:
Journal of the American College of Cardiology|October 3, 2015
Meta-Analyses of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation: Do Bleeding and Stent Thrombosis Weigh Similar on Mortality?Davide Capodanno, Giuseppe Gargiulo, Sergio Buccheri, et al.
BMJ (Clinical Research Ed.)|November 6, 2015
Treatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patientsDaniele Giacoppo, Giuseppe Gargiulo, Patrizia Aruta, et al.
Expert Review of Cardiovascular Therapy|November 8, 2016
Risk stratification after ST-segment elevation myocardial infarctionSergio Buccheri, Piera Capranzano, Antonio Condorelli, et al.
Circulation. Cardiovascular Interventions|January 13, 2018
Decision Analytic Markov Model Weighting Expected Benefits and Current Limitations of First-Generation Bioresorbable Vascular Scaffolds: Implications for Manufacturers and Next Device IterationsDavide Capodanno, Sergio Buccheri, Sara Romano, et al.
European Heart Journal. Acute Cardiovascular Care|March 10, 2015
Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary PCI: An updated meta-analysis of 10,350 patients from five randomized clinical trialsDavide Capodanno, Giuseppe Gargiulo, Piera Capranzano, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 19, 2015
Bioresorbable vascular scaffolds in left main coronary artery diseaseBert Everaert, Piera Capranzano, Corrado Tamburino, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 1, 2016
Update on clinical evidence (Part II): A summary of the main post market studiesCorrado Tamburino, Piera Capranzano, Bruno Francaviglia, et al.
International Journal of Cardiology|February 21, 2024
Monotherapy with P2Y<sub>12</sub>-inhibitors after dual antiplatelet therapy: Filling gaps in evidenceGiuseppe Andò, Luca Lombardo, Giulia Alagna, et al.
Revista Espanola De Cardiologia (English Ed.)|July 26, 2011
Impact of adjunctive cilostazol therapy versus high maintenance dose of clopidogrel in suboptimal responders with diabetes mellitusJosé L Ferreiro, Masafumi Ueno, Bhaloo Desai, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 9, 2008
Early discharge in acute myocardial infarction after clinical and angiographic risk assessmentGiuseppina Branca, Davide Capodanno, Piera Capranzano, et al.
Pageof 23

Showing results (61-70 of 224) with videos related to

Sort By:
Pageof 23
Journal of the American College of Cardiology|October 3, 2015
Meta-Analyses of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation: Do Bleeding and Stent Thrombosis Weigh Similar on Mortality?Davide Capodanno, Giuseppe Gargiulo, Sergio Buccheri, et al.
BMJ (Clinical Research Ed.)|November 6, 2015
Treatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patientsDaniele Giacoppo, Giuseppe Gargiulo, Patrizia Aruta, et al.
Expert Review of Cardiovascular Therapy|November 8, 2016
Risk stratification after ST-segment elevation myocardial infarctionSergio Buccheri, Piera Capranzano, Antonio Condorelli, et al.
Circulation. Cardiovascular Interventions|January 13, 2018
Decision Analytic Markov Model Weighting Expected Benefits and Current Limitations of First-Generation Bioresorbable Vascular Scaffolds: Implications for Manufacturers and Next Device IterationsDavide Capodanno, Sergio Buccheri, Sara Romano, et al.
European Heart Journal. Acute Cardiovascular Care|March 10, 2015
Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary PCI: An updated meta-analysis of 10,350 patients from five randomized clinical trialsDavide Capodanno, Giuseppe Gargiulo, Piera Capranzano, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 19, 2015
Bioresorbable vascular scaffolds in left main coronary artery diseaseBert Everaert, Piera Capranzano, Corrado Tamburino, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 1, 2016
Update on clinical evidence (Part II): A summary of the main post market studiesCorrado Tamburino, Piera Capranzano, Bruno Francaviglia, et al.
International Journal of Cardiology|February 21, 2024
Monotherapy with P2Y<sub>12</sub>-inhibitors after dual antiplatelet therapy: Filling gaps in evidenceGiuseppe Andò, Luca Lombardo, Giulia Alagna, et al.
Revista Espanola De Cardiologia (English Ed.)|July 26, 2011
Impact of adjunctive cilostazol therapy versus high maintenance dose of clopidogrel in suboptimal responders with diabetes mellitusJosé L Ferreiro, Masafumi Ueno, Bhaloo Desai, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 9, 2008
Early discharge in acute myocardial infarction after clinical and angiographic risk assessmentGiuseppina Branca, Davide Capodanno, Piera Capranzano, et al.
Pageof 23